277 related articles for article (PubMed ID: 18751422)
1. The significance of gastrectomy in advanced gastric cancer patients with non-curative factors.
Miyagaki H; Fujitani K; Tsujinaka T; Hirao M; Yasui M; Kashiwazaki M; Ikenaga M; Miyazaki M; Mishima H; Nakamori S
Anticancer Res; 2008; 28(4C):2379-84. PubMed ID: 18751422
[TBL] [Abstract][Full Text] [Related]
2. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
4. Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Fujii S; Otsuka Y; Akiyama H; Ono HA; Kosaka T; Ichikawa Y; Shimada H
Anticancer Res; 2008; 28(2B):1309-15. PubMed ID: 18505071
[TBL] [Abstract][Full Text] [Related]
5. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
8. Postoperative chemotherapy in elderly patients with advanced gastric cancer.
Hanazaki K; Mochizuki Y; Igarashi J; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
Hepatogastroenterology; 2000; 47(36):1761-4. PubMed ID: 11149051
[TBL] [Abstract][Full Text] [Related]
9. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors.
Kunieda K; Saji S; Sugiyama Y; Osada S; Sano J; Nagao N; Takahashi T; Takagi Y; Arai Y
Surg Today; 2002; 32(7):587-93. PubMed ID: 12111514
[TBL] [Abstract][Full Text] [Related]
11. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor size in T3 gastric cancer.
Liu X; Xu Y; Long Z; Zhu H; Wang Y
Ann Surg Oncol; 2009 Jul; 16(7):1875-82. PubMed ID: 19373514
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
15. The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
Oh SJ; Hyung WJ; Li C; Song J; Kang W; Rha SY; Chung HC; Choi SH; Noh SH;
J Surg Oncol; 2009 Apr; 99(5):275-80. PubMed ID: 19152367
[TBL] [Abstract][Full Text] [Related]
16. Better 5-year survival rate following curative gastrectomy in overweight patients.
Tokunaga M; Hiki N; Fukunaga T; Ohyama S; Yamaguchi T; Nakajima T
Ann Surg Oncol; 2009 Dec; 16(12):3245-51. PubMed ID: 19636624
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors and usefulness of chemotherapy with S-1 in patients received gastrectomy for stage IV gastric cancer].
Maehara N; Hidaka H; Nagaike K; Nakashima S; Hotokezaka M; Chijiiwa K
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1111-4. PubMed ID: 19620798
[TBL] [Abstract][Full Text] [Related]
18. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer.
Cheong JH; Shen JY; Song CS; Hyung WJ; Shen JG; Choi SH; Noh SH
Ann Surg Oncol; 2007 Jan; 14(1):61-8. PubMed ID: 17058123
[TBL] [Abstract][Full Text] [Related]
19. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
20. Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma.
Erturk S; Ersan Y; Cicek Y; Dogusoy G; Senocak M
Surg Today; 2003; 33(4):254-8. PubMed ID: 12707818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
